Report cover image

Global Skin Topical Medications Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 192 Pages
SKU # APRC20282384

Description

Summary

According to APO Research, The global Skin Topical Medications market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Skin Topical Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Skin Topical Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Skin Topical Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Skin Topical Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Skin Topical Medications include Regeneron, Shanghai Xiao Fang Pharmaceutical, Teva, Sandoz, Mylan, Pfizer, Novartis, LEO Pharma and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Skin Topical Medications, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Skin Topical Medications, also provides the revenue of main regions and countries. Of the upcoming market potential for Skin Topical Medications, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Skin Topical Medications revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Skin Topical Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Skin Topical Medications revenue, projected growth trends, production technology, application and end-user industry.

Skin Topical Medications Segment by Company

Regeneron
Shanghai Xiao Fang Pharmaceutical
Teva
Sandoz
Mylan
Pfizer
Novartis
LEO Pharma
Johnson & Johnson
GlaxoSmithKline
Galderma
Celgene
Allergan
AbbVie
Skin Topical Medications Segment by Type

Antibacterial Agent
Antifungal Agent
Emollient
Others
Skin Topical Medications Segment by Application

For Youth
For the Elderly
For Children
Skin Topical Medications Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Topical Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Topical Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Topical Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Skin Topical Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Skin Topical Medications company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Skin Topical Medications revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Skin Topical Medications Market by Type
1.2.1 Global Skin Topical Medications Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Antibacterial Agent
1.2.3 Antifungal Agent
1.2.4 Emollient
1.2.5 Others
1.3 Skin Topical Medications Market by Application
1.3.1 Global Skin Topical Medications Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 For Youth
1.3.3 For the Elderly
1.3.4 For Children
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Skin Topical Medications Market Dynamics
2.1 Skin Topical Medications Industry Trends
2.2 Skin Topical Medications Industry Drivers
2.3 Skin Topical Medications Industry Opportunities and Challenges
2.4 Skin Topical Medications Industry Restraints
3 Global Growth Perspective
3.1 Global Skin Topical Medications Market Perspective (2020-2031)
3.2 Global Skin Topical Medications Growth Trends by Region
3.2.1 Global Skin Topical Medications Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Skin Topical Medications Market Size by Region (2020-2025)
3.2.3 Global Skin Topical Medications Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Skin Topical Medications Revenue by Players
4.1.1 Global Skin Topical Medications Revenue by Players (2020-2025)
4.1.2 Global Skin Topical Medications Revenue Market Share by Players (2020-2025)
4.1.3 Global Skin Topical Medications Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Skin Topical Medications Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Skin Topical Medications Key Players Headquarters & Area Served
4.4 Global Skin Topical Medications Players, Product Type & Application
4.5 Global Skin Topical Medications Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Skin Topical Medications Market CR5 and HHI
4.6.3 2024 Skin Topical Medications Tier 1, Tier 2, and Tier 3
5 Skin Topical Medications Market Size by Type
5.1 Global Skin Topical Medications Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Skin Topical Medications Revenue by Type (2020-2031)
5.3 Global Skin Topical Medications Revenue Market Share by Type (2020-2031)
6 Skin Topical Medications Market Size by Application
6.1 Global Skin Topical Medications Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Skin Topical Medications Revenue by Application (2020-2031)
6.3 Global Skin Topical Medications Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Regeneron
7.1.1 Regeneron Comapny Information
7.1.2 Regeneron Business Overview
7.1.3 Regeneron Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.1.4 Regeneron Skin Topical Medications Product Portfolio
7.1.5 Regeneron Recent Developments
7.2 Shanghai Xiao Fang Pharmaceutical
7.2.1 Shanghai Xiao Fang Pharmaceutical Comapny Information
7.2.2 Shanghai Xiao Fang Pharmaceutical Business Overview
7.2.3 Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.2.4 Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Product Portfolio
7.2.5 Shanghai Xiao Fang Pharmaceutical Recent Developments
7.3 Teva
7.3.1 Teva Comapny Information
7.3.2 Teva Business Overview
7.3.3 Teva Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.3.4 Teva Skin Topical Medications Product Portfolio
7.3.5 Teva Recent Developments
7.4 Sandoz
7.4.1 Sandoz Comapny Information
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.4.4 Sandoz Skin Topical Medications Product Portfolio
7.4.5 Sandoz Recent Developments
7.5 Mylan
7.5.1 Mylan Comapny Information
7.5.2 Mylan Business Overview
7.5.3 Mylan Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.5.4 Mylan Skin Topical Medications Product Portfolio
7.5.5 Mylan Recent Developments
7.6 Pfizer
7.6.1 Pfizer Comapny Information
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.6.4 Pfizer Skin Topical Medications Product Portfolio
7.6.5 Pfizer Recent Developments
7.7 Novartis
7.7.1 Novartis Comapny Information
7.7.2 Novartis Business Overview
7.7.3 Novartis Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.7.4 Novartis Skin Topical Medications Product Portfolio
7.7.5 Novartis Recent Developments
7.8 LEO Pharma
7.8.1 LEO Pharma Comapny Information
7.8.2 LEO Pharma Business Overview
7.8.3 LEO Pharma Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.8.4 LEO Pharma Skin Topical Medications Product Portfolio
7.8.5 LEO Pharma Recent Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Comapny Information
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.9.4 Johnson & Johnson Skin Topical Medications Product Portfolio
7.9.5 Johnson & Johnson Recent Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Comapny Information
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.10.4 GlaxoSmithKline Skin Topical Medications Product Portfolio
7.10.5 GlaxoSmithKline Recent Developments
7.11 Galderma
7.11.1 Galderma Comapny Information
7.11.2 Galderma Business Overview
7.11.3 Galderma Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.11.4 Galderma Skin Topical Medications Product Portfolio
7.11.5 Galderma Recent Developments
7.12 Celgene
7.12.1 Celgene Comapny Information
7.12.2 Celgene Business Overview
7.12.3 Celgene Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.12.4 Celgene Skin Topical Medications Product Portfolio
7.12.5 Celgene Recent Developments
7.13 Allergan
7.13.1 Allergan Comapny Information
7.13.2 Allergan Business Overview
7.13.3 Allergan Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.13.4 Allergan Skin Topical Medications Product Portfolio
7.13.5 Allergan Recent Developments
7.14 AbbVie
7.14.1 AbbVie Comapny Information
7.14.2 AbbVie Business Overview
7.14.3 AbbVie Skin Topical Medications Revenue and Gross Margin (2020-2025)
7.14.4 AbbVie Skin Topical Medications Product Portfolio
7.14.5 AbbVie Recent Developments
8 North America
8.1 North America Skin Topical Medications Revenue (2020-2031)
8.2 North America Skin Topical Medications Revenue by Type (2020-2031)
8.2.1 North America Skin Topical Medications Revenue by Type (2020-2025)
8.2.2 North America Skin Topical Medications Revenue by Type (2026-2031)
8.3 North America Skin Topical Medications Revenue Share by Type (2020-2031)
8.4 North America Skin Topical Medications Revenue by Application (2020-2031)
8.4.1 North America Skin Topical Medications Revenue by Application (2020-2025)
8.4.2 North America Skin Topical Medications Revenue by Application (2026-2031)
8.5 North America Skin Topical Medications Revenue Share by Application (2020-2031)
8.6 North America Skin Topical Medications Revenue by Country
8.6.1 North America Skin Topical Medications Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Skin Topical Medications Revenue by Country (2020-2025)
8.6.3 North America Skin Topical Medications Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Skin Topical Medications Revenue (2020-2031)
9.2 Europe Skin Topical Medications Revenue by Type (2020-2031)
9.2.1 Europe Skin Topical Medications Revenue by Type (2020-2025)
9.2.2 Europe Skin Topical Medications Revenue by Type (2026-2031)
9.3 Europe Skin Topical Medications Revenue Share by Type (2020-2031)
9.4 Europe Skin Topical Medications Revenue by Application (2020-2031)
9.4.1 Europe Skin Topical Medications Revenue by Application (2020-2025)
9.4.2 Europe Skin Topical Medications Revenue by Application (2026-2031)
9.5 Europe Skin Topical Medications Revenue Share by Application (2020-2031)
9.6 Europe Skin Topical Medications Revenue by Country
9.6.1 Europe Skin Topical Medications Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Skin Topical Medications Revenue by Country (2020-2025)
9.6.3 Europe Skin Topical Medications Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Skin Topical Medications Revenue (2020-2031)
10.2 China Skin Topical Medications Revenue by Type (2020-2031)
10.2.1 China Skin Topical Medications Revenue by Type (2020-2025)
10.2.2 China Skin Topical Medications Revenue by Type (2026-2031)
10.3 China Skin Topical Medications Revenue Share by Type (2020-2031)
10.4 China Skin Topical Medications Revenue by Application (2020-2031)
10.4.1 China Skin Topical Medications Revenue by Application (2020-2025)
10.4.2 China Skin Topical Medications Revenue by Application (2026-2031)
10.5 China Skin Topical Medications Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Skin Topical Medications Revenue (2020-2031)
11.2 Asia Skin Topical Medications Revenue by Type (2020-2031)
11.2.1 Asia Skin Topical Medications Revenue by Type (2020-2025)
11.2.2 Asia Skin Topical Medications Revenue by Type (2026-2031)
11.3 Asia Skin Topical Medications Revenue Share by Type (2020-2031)
11.4 Asia Skin Topical Medications Revenue by Application (2020-2031)
11.4.1 Asia Skin Topical Medications Revenue by Application (2020-2025)
11.4.2 Asia Skin Topical Medications Revenue by Application (2026-2031)
11.5 Asia Skin Topical Medications Revenue Share by Application (2020-2031)
11.6 Asia Skin Topical Medications Revenue by Country
11.6.1 Asia Skin Topical Medications Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Skin Topical Medications Revenue by Country (2020-2025)
11.6.3 Asia Skin Topical Medications Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Skin Topical Medications Revenue (2020-2031)
12.2 SAMEA Skin Topical Medications Revenue by Type (2020-2031)
12.2.1 SAMEA Skin Topical Medications Revenue by Type (2020-2025)
12.2.2 SAMEA Skin Topical Medications Revenue by Type (2026-2031)
12.3 SAMEA Skin Topical Medications Revenue Share by Type (2020-2031)
12.4 SAMEA Skin Topical Medications Revenue by Application (2020-2031)
12.4.1 SAMEA Skin Topical Medications Revenue by Application (2020-2025)
12.4.2 SAMEA Skin Topical Medications Revenue by Application (2026-2031)
12.5 SAMEA Skin Topical Medications Revenue Share by Application (2020-2031)
12.6 SAMEA Skin Topical Medications Revenue by Country
12.6.1 SAMEA Skin Topical Medications Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Skin Topical Medications Revenue by Country (2020-2025)
12.6.3 SAMEA Skin Topical Medications Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.